Molly Henderson
Chief Executive Officer, VirtualScopics, Inc.
Companies
- Phathom Pharmaceuticals, Inc.Chief financial officer Apr 6, 2022 to Oct 7, 20251
- UroGen Pharma Ltd.Chief financial officer Oct 5, 2020 to Feb 2, 20222
- AdvaxisChief financial officer Jun 8, 2018 to May 5, 20203
- Iovance BiotherapeuticsChief financial officer Jun 10, 2015 to Jun 15, 20164
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Phathom Pharmaceuticals, Inc. PHAT91,779 shares5$688.3K at $7.50Apr 8, 2025
- UroGen Pharma Ltd. URGN5,248 shares6$190.8K at $36.36Jan 31, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Apr 7, 2025Sold 3,678 shares at $4.55 of Phathom Pharmaceuticals, Inc.5
- Feb 27, 2025Granted 72,000 shares of Phathom Pharmaceuticals, Inc.7
- Jan 21, 2025Sold 6,583 shares at $6.59 of Phathom Pharmaceuticals, Inc.8
- Dec 19, 2024Sold 1,291 shares at $8.00 of Phathom Pharmaceuticals, Inc.9
- Jul 15, 2024Sold 4,325 shares at $11.72 of Phathom Pharmaceuticals, Inc.10
- May 31, 2024Granted 7,500 shares of Phathom Pharmaceuticals, Inc.11
- Apr 8, 2024Sold 3,435 shares at $11.10 of Phathom Pharmaceuticals, Inc.12
- Jan 19, 2024Sold 6,307 shares at $7.75 of Phathom Pharmaceuticals, Inc.13
- Nov 20, 2023Sold 2,127 shares at $7.24 of Phathom Pharmaceuticals, Inc.14
- Nov 1, 2023Sold 11,681 shares at $8.95 of Phathom Pharmaceuticals, Inc.15
- Nov 1, 2023Sold 811 shares at $7.80 of Phathom Pharmaceuticals, Inc.15
- Nov 1, 2023Granted 22,500 shares of Phathom Pharmaceuticals, Inc.15
- Jul 14, 2023Granted 25,000 shares of Phathom Pharmaceuticals, Inc.16
- Jul 14, 2023Granted 25,000 shares at $1.00 of Phathom Pharmaceuticals, Inc.17
- Jun 2, 2023Sold 1,960 shares at $11.41 of Phathom Pharmaceuticals, Inc.18
- May 22, 2023Sold 2,110 shares at $12.87 of Phathom Pharmaceuticals, Inc.19
- Apr 6, 2023Sold 3,439 shares at $7.27 of Phathom Pharmaceuticals, Inc.20
- Mar 1, 2023Sold 2,032 shares at $8.53 of Phathom Pharmaceuticals, Inc.21
- Jan 19, 2023Granted 33,000 shares of Phathom Pharmaceuticals, Inc.22
- Nov 21, 2022Sold 2,159 shares at $9.60 of Phathom Pharmaceuticals, Inc.23
- Sep 1, 2022Granted 7,500 shares of Phathom Pharmaceuticals, Inc.24
- May 19, 2022Granted 12,000 shares of Phathom Pharmaceuticals, Inc.25
- May 13, 2022Bought 6,000 shares of Phathom Pharmaceuticals, Inc.26
- Apr 5, 2022Granted 20,000 shares of Phathom Pharmaceuticals, Inc.27
- Jan 31, 2022Sold 331 shares at $7.58 of UroGen Pharma Ltd.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARAdvaxis, Chief financial officer
- 4
- 5
- 6
- 7SEC EDGARForm 4 filed Mar 3, 2025
- 8SEC EDGARForm 4 filed Jan 23, 2025
- 9SEC EDGARForm 4 filed Dec 20, 2024
- 10SEC EDGARForm 4 filed Jul 17, 2024
- 11SEC EDGARForm 4 filed May 31, 2024
- 12SEC EDGARForm 4 filed Apr 10, 2024
- 13SEC EDGARForm 4 filed Jan 22, 2024
- 14SEC EDGARForm 4 filed Nov 21, 2023
- 15SEC EDGARForm 4 filed Nov 3, 2023
- 16SEC EDGARForm 4 filed Jul 21, 2023
- 17SEC EDGARForm 4 filed Jul 17, 2023
- 18SEC EDGARForm 4 filed Jun 5, 2023
- 19SEC EDGARForm 4 filed May 23, 2023
- 20SEC EDGARForm 4 filed Apr 7, 2023
- 21SEC EDGARForm 4 filed Mar 3, 2023
- 22SEC EDGARForm 4 filed Jan 20, 2023
- 23SEC EDGARForm 4 filed Nov 23, 2022
- 24SEC EDGARForm 4 filed Sep 2, 2022
- 25SEC EDGARForm 4 filed May 20, 2022
- 26SEC EDGARForm 4 filed May 16, 2022
- 27SEC EDGARForm 4 filed Apr 6, 2022